Jackson, Grant Investment Advisers, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Jackson, Grant Investment Advisers, Inc.
- $265 Million
- Q3 2024
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 31 shares of REGN stock, worth $22,217. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31
Previous 31
-0.0%
Holding current value
$22,217
Previous $32,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.68 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.05 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.37 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.51 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.08 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...